Hughes ADDIN EN.CITE European Genetic risk score of 5 0.07 (-0.12, 0.26) 0.47 β 2013 7,979 (2)* SBP (mm Hg) 2.3% Caucasian SUA-related SNPs Yang ADDIN EN.CITE Genetic risk score of 8 -0.83 (-1.96, 0.30) 0.15 β 2010 American 20,673 (5)* SBP (mm Hg) 6.0% SUA-related SNPs Parsa ADDIN EN.CITE SBP-Clinic visit 1 0.08 (-1.70, 1.86) 0.38 2012 USA 868 rs16890979 in SCL2A9 NA MD (mm Hg) Parsa ADDIN EN.CITE SBP-High-salt 24-h 2.20 (0.65, 3.75) 0.01 2012 USA 868 rs16890979 in SCL2A9 NA MD (mm Hg) Parsa ADDIN EN.CITE SBP-Low-salt 24-h 1.48 (0.09, 2.87) 0.04 2012 USA 868 rs16890979 in SCL2A9 NA MD (mm Hg) Parsa ADDIN SBP-Salt sensitivity 0.62 (-0.34, 1.58) 0.21 EN.CITE 2012 USA 868 rs16890979 in SCL2A9 NA MD 24-h (mm Hg)
Hughes ADDIN EN.CITE 2013 European Caucasian 7,979 (2)* SBP (mm Hg) Genetic risk score of 5 SUA-related SNPs 2.3% β 0.07 (-0.12, 0.26) 0.47 Yang ADDIN EN.CITE 2010 American 20,673 (5)* SBP (mm Hg) Genetic risk score of 8 SUA-related SNPs 6.0% β -0.83 (-1.96, 0.30) 0.15 Parsa ADDIN EN.CITE 2012 USA 868 SBP-Clinic visit 1 (mm Hg) rs16890979 in SCL2A9 NA MD 0.08 (-1.70, 1.86) 0.38 Parsa ADDIN EN.CITE 2012 USA 868 SBP-High-salt 24-h (mm Hg) rs16890979 in SCL2A9 NA MD 2.20 (0.65, 3.75) 0.01 Parsa ADDIN EN.CITE 2012 USA 868 SBP-Low-salt 24-h (mm Hg) rs16890979 in SCL2A9 NA MD 1.48 (0.09, 2.87) 0.04 Parsa ADDIN EN.CITE 2012 USA 868 SBP-Salt sensitivity 24-h (mm Hg) rs16890979 in SCL2A9 NA MD 0.62 (-0.34, 1.58) 0.21
Supplementary%20material_v7%20-%20Final-2.docx